Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SUMO-1 and p53.

Frauke Melchior1, Ludger Hengst

  • 1Max-Planck Institute of Biochemistry, Am Klopferspitz 18a, D-82152 Martinsried Germany. melchior@biochem.mpg.de

Cell Cycle (Georgetown, Tex.)
|November 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement C7 and clusterin form a complex in circulation.

Frontiers in immunology·2024
Same author

Fasting-sensitive SUMO-switch on Prox1 controls hepatic cholesterol metabolism.

EMBO reports·2023
Same author

EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27<sup>Kip1</sup>.

Cells·2023
Same author

Inability to phosphorylate Y88 of p27<sup>Kip1</sup> enforces reduced p27 protein levels and accelerates leukemia progression.

Leukemia·2022
Same author

SCF<sup>Fbxw5</sup> targets kinesin-13 proteins to facilitate ciliogenesis.

The EMBO journal·2021
Same author

Stimulation of c-Jun/AP-1-Activity by the Cell Cycle Inhibitor p57<sup>Kip2</sup>.

Frontiers in cell and developmental biology·2021

Posttranslational modifications regulate the tumor suppressor p53. This study reviews SUMOylation (Small Ubiquitin-related Modifier) and its controversial role in p53 transcriptional activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The tumor suppressor p53's activity is modulated by various posttranslational modifications.
  • SUMOylation (Small Ubiquitin-related Modifier) is a reversible covalent modification recently identified as a regulator of protein function.
  • The precise role of SUMOylation in p53 transcriptional activity remains debated.

Purpose of the Study:

  • To summarize the SUMOylation pathway.
  • To discuss the implications of SUMOylation for p53 function.

Main Methods:

  • Literature review of SUMOylation pathways.
  • Analysis of studies investigating SUMOylation and p53 interactions.

Main Results:

Related Experiment Videos

  • SUMOylation, similar to ubiquitination, involves reversible attachment to target proteins.
  • SUMOylation can alter protein interactions, localization, enzymatic activity, and stability.
  • Evidence suggests SUMOylation may influence p53 transcriptional activity, though this is controversial.

    • Conclusions:

    • SUMOylation is a significant posttranslational modification with diverse molecular consequences.
    • Further research is needed to clarify the exact role and mechanisms of SUMOylation in regulating p53 function.